Adalimumab-associated antiphospholipid syndrome: A case report and review of the literature

Clinical Rheumatology

Volumn 32, Issue 7, 2013, Pages 1095-1098

  Hemmati, Iman ^a   Kur, Jason ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adalimumab; Anti TNF; Antiphospholipid syndrome; Vasculitis

Indexed keywords

ADALIMUMAB; CALCIUM; CARDIOLIPIN ANTIBODY; CELECOXIB; CLOPIDOGREL; CREATININE; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; PIPERACILLIN PLUS TAZOBACTAM; STEROID; TINZAPARIN; VANCOMYCIN; VITAMIN D; ZOLEDRONIC ACID;

AGED; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; ARTIFICIAL VENTILATION; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CASE REPORT; CONFERENCE PAPER; DACTYLITIS; ENTHESOPATHY; FEMALE; FLUID RESUSCITATION; HUMAN; INTENSIVE CARE UNIT; JOINT SWELLING; LEUKOCYTOSIS; LOW BACK PAIN; LUMBAR SPINE; MEDICAL HISTORY; MORNING STIFFNESS; NEUTROPHILIA; OSTEOPOROSIS; PHYSICAL EXAMINATION; PLANTAR FASCIITIS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RANGE OF MOTION; SACROILIITIS; SEPTIC SHOCK; SPINE RADIOGRAPHY; SPONDYLOARTHROPATHY; SYNOVITIS; TENDINITIS; VASCULITIS; VITAMIN SUPPLEMENTATION;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOGLOBULIN M; INFLAMMATION; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 84880146408     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2244-0     Document Type: Conference Paper

References (9)

1. Ortel TL (2012) Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol 87(Suppl 1):75-81, Review
2. Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP (2012) Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis 72(4):517-524
3. Vereckei E, Kriván G, Réti M, Szodoray P, Poór G, Kiss E (2010) Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis. Scand J Rheumatol 39(2):175-177
4. Bakkour W, Coulson IH, Sahasrabudhe N (2012) Adalimumab-induced medium-sized vessel vasculitis. Clin Exp Dermatol 37(5):562-564
5. Orpin SD, Majmudar VB, Soon C, Azam NA, Salim A (2006) Adalimumab causing vasculitis. Br J Dermatol 154(5):998-999
6. Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA (2010) Henoch-Schönlein purpura complicating adalimumab therapy for Crohn's disease. World J Gastrointest Pharmacol Ther 1(5):119-122
7. Marques I, Lagos A, Reis J, Pinto A, Neves B (2012) Reversible Henoch-Schönlein purpura complicating adalimumab therapy. J Crohns Colitis 6(7):796-799
8. Scheinfeld N (2004) A comprehensive review and evaluation of the side effects of the tumor necrosis factor a blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 15:280-294 (Pubitemid 39423287)
9. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30(10):2287-2291 (Pubitemid 37221866)